Mycoplasma infection in human.

4 posts / 0 new
Last post
ramesh padodara
ramesh padodara's picture
Mycoplasma infection in human.

What does Mycoplasma do when it enter through parental (SC or IV) in human?
Please reply me soon.

Tirumal Rao
Tirumal Rao's picture
Dear doctor,

Dear doctor,

different kinds of mycoplasma species are ther for example M. pneumoniae progressing to a dry cough within a few days. Gradually, fever, fatigue, muscle aches, and a cough that produces thin sputum (spit or phlegm) will emerge. Nonrespiratory symptoms may occur too: abdominal pain, headache, and diarrhea; about 20% of patients may have ear pain.
At this time, there are no vaccines for mycoplasma infection. It is difficult to control its spread, especially in a group setting. The best measures are still the simplest ones. Avoid exposure to people with respiratory infections whenever possible. A person who has a respiratory infection should cover the face while coughing or sneezing.

Thanks ,

Kvachhani's picture

when mycoplasma injected sc, at the site of injection it produce neutrophilic infiltraiton initioly, but as you know neutrophil unable to neutralize it due to glycoprotein of the cell wall of mycoplasma and resulting in to infiltration of chronic inflammatory cells at the site. if by chance it gose to local circulation or systemic circulation,  it produce symptom of infection (depands on spp. of mycoplasma and host's immunity). if no escape has occur from the site of entry it cause granuloma production typically with gaint cells and epitheloid cells along with other chronic inflammatory cells infiltration.
If mycoplasma enters through iv it lodged in any part of the body, and again dempands on the spp. of mycoplasma and host's immunity it produce either symptom of infection or encircled by granuloma production.

hilltrekker's picture
If you are injecting the

If you are injecting the organism parenterally, either it will be destroyed by the host's immune defense system or will lead to the local/systemic or both infection in the body. The final outcome will depend upon the pathogenicity of the Mycoplasma sp. and immune mechanism in the host.